Effective clearance of Ara-U the major metabolite of cytosine arabinoside (Ara-C) by hemodialysis in a patient with lymphoma and end-stage renal failure

Author： Radeski Dejan   Cull Gavin   Cain Michael   Hackett L.   Ilett Kenneth  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.67, Iss.4, 2011-04, pp. : 765-768

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C

By Chamberlain Marc   Johnston Sandra   Horn Alixis   Glantz Michael  

Journal of Neuro-Oncology, Vol. 91, Iss. 3, 2009-02 ,pp. : 271-277

Springer Publishing Company

Access to resources Recommend Favorite

Is there different risk of cancer among end‐stage renal disease patients undergoing hemodialysis and peritoneal dialysis?

By  

Cancer Medicine, Vol. 7, Iss. 2, 2018-02 ,pp. : 485-498

John Wiley & Sons Inc

Access to resources Recommend Favorite

Augmentation of 1- -d-Arabinofuranosylcytosine (Ara-C) cytotoxicity in leukaemia cells by co-administration with antisignalling drugs

By Freund A.   Boos J.   Harkin S.   Schultze-Mosgau M.   Veerman G.   Peters G.J.   Gescher A.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 895-901

Elsevier

Access to resources Recommend Favorite

High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study

By Tedeschi Alessandra   Montillo Marco   Strocchi Elena   Cafro Anna   Tresoldi Elisabetta   Intropido Liliana   Nichelatti Michele   Marbello Laura   Baratè Claudia   Camaggi Carlo   Morra Enrica  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 771-779

Springer Publishing Company

Access to resources Recommend Favorite

Blockade of CD82 by a monoclonal antibody potentiates anti‐leukemia effects of AraC in vivo

By  

Cancer Medicine, Vol. 4, Iss. 9, 2015-09 ,pp. : 1426-1431

John Wiley & Sons Inc

Access to resources Recommend Favorite